View in EDS HTML Full Text PDF Full Text

Phase 1/2a Safety and Immunogenicity of an Adenovirus 26 Vector Respiratory Syncytial Virus (RSV) Vaccine Encoding Prefusion F in Adults 18-50 Years and RSV-Seropositive Children 12-24 Months.

Saved in:
Bibliographic Details
Title: Phase 1/2a Safety and Immunogenicity of an Adenovirus 26 Vector Respiratory Syncytial Virus (RSV) Vaccine Encoding Prefusion F in Adults 18-50 Years and RSV-Seropositive Children 12-24 Months.
Authors: Stuart ASV; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Virta M; Tampere University, Tampere, Finland., Williams K; Janssen Vaccines & Prevention BV, Leiden, The Netherlands., Seppa I; Tampere University, Tampere, Finland., Hartvickson R; Axtell Clinic, Newton, Kansas, USA., Greenland M; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Omoruyi E; Janssen Infectious Diseases, Beerse, Belgium., Bastian AR; Janssen Vaccines & Prevention BV, Leiden, The Netherlands., Haazen W; Janssen Vaccines & Prevention BV, Leiden, The Netherlands., Salisch N; Janssen Vaccines & Prevention BV, Leiden, The Netherlands., Gymnopoulou E; Janssen Infectious Diseases, Beerse, Belgium., Callendret B; Janssen Vaccines & Prevention BV, Leiden, The Netherlands., Faust SN; NIHR Southampton Clinical Research Facility and NIHR Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, United Kingdom., Snape MD; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.; Oxford NIHR - Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Heijnen E; Janssen Vaccines & Prevention BV, Leiden, The Netherlands.
Source: The Journal of infectious diseases [J Infect Dis] 2022 Dec 28; Vol. 227 (1), pp. 71-82.
Publication Type: Randomized Controlled Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36259542
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phase 1/2a Safety and Immunogenicity of an Adenovirus 26 Vector Respiratory Syncytial Virus (RSV) Vaccine Encoding Prefusion F in Adults 18-50 Years and RSV-Seropositive Children 12-24 Months.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Stuart+ASV%22">Stuart ASV</searchLink>; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Virta+M%22">Virta M</searchLink>; Tampere University, Tampere, Finland.<br /><searchLink fieldCode="AU" term="%22Williams+K%22">Williams K</searchLink>; Janssen Vaccines & Prevention BV, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Seppa+I%22">Seppa I</searchLink>; Tampere University, Tampere, Finland.<br /><searchLink fieldCode="AU" term="%22Hartvickson+R%22">Hartvickson R</searchLink>; Axtell Clinic, Newton, Kansas, USA.<br /><searchLink fieldCode="AU" term="%22Greenland+M%22">Greenland M</searchLink>; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Omoruyi+E%22">Omoruyi E</searchLink>; Janssen Infectious Diseases, Beerse, Belgium.<br /><searchLink fieldCode="AU" term="%22Bastian+AR%22">Bastian AR</searchLink>; Janssen Vaccines & Prevention BV, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Haazen+W%22">Haazen W</searchLink>; Janssen Vaccines & Prevention BV, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Salisch+N%22">Salisch N</searchLink>; Janssen Vaccines & Prevention BV, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Gymnopoulou+E%22">Gymnopoulou E</searchLink>; Janssen Infectious Diseases, Beerse, Belgium.<br /><searchLink fieldCode="AU" term="%22Callendret+B%22">Callendret B</searchLink>; Janssen Vaccines & Prevention BV, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Faust+SN%22">Faust SN</searchLink>; NIHR Southampton Clinical Research Facility and NIHR Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.; Faculty of Medicine and Institute for Life Sciences, University of Southampton, Southampton, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Snape+MD%22">Snape MD</searchLink>; Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom.; Oxford NIHR - Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Heijnen+E%22">Heijnen E</searchLink>; Janssen Vaccines & Prevention BV, Leiden, The Netherlands.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220413675%22">The Journal of infectious diseases</searchLink> [J Infect Dis] 2022 Dec 28; Vol. 227 (1), pp. 71-82.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Randomized Controlled Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0413675 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6613 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200221899%22">00221899 </searchLink><i>NLM ISO Abbreviation: </i>J Infect Dis <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36259542
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/infdis/jiac407
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 71
    Titles:
      – TitleFull: Phase 1/2a Safety and Immunogenicity of an Adenovirus 26 Vector Respiratory Syncytial Virus (RSV) Vaccine Encoding Prefusion F in Adults 18-50 Years and RSV-Seropositive Children 12-24 Months.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Stuart ASV
      – PersonEntity:
          Name:
            NameFull: Virta M
      – PersonEntity:
          Name:
            NameFull: Williams K
      – PersonEntity:
          Name:
            NameFull: Seppa I
      – PersonEntity:
          Name:
            NameFull: Hartvickson R
      – PersonEntity:
          Name:
            NameFull: Greenland M
      – PersonEntity:
          Name:
            NameFull: Omoruyi E
      – PersonEntity:
          Name:
            NameFull: Bastian AR
      – PersonEntity:
          Name:
            NameFull: Haazen W
      – PersonEntity:
          Name:
            NameFull: Salisch N
      – PersonEntity:
          Name:
            NameFull: Gymnopoulou E
      – PersonEntity:
          Name:
            NameFull: Callendret B
      – PersonEntity:
          Name:
            NameFull: Faust SN
      – PersonEntity:
          Name:
            NameFull: Snape MD
      – PersonEntity:
          Name:
            NameFull: Heijnen E
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 28
              M: 12
              Text: 2022 Dec 28
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 1537-6613
          Numbering:
            – Type: volume
              Value: 227
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: The Journal of infectious diseases
              Type: main
ResultId 1